New mechanism for inhibition of the immunoproteasome

The potential drug that the researchers developed is based on the epoxyketon ONX 0914

World Lupus Day

Oxford Gene Technology marks World Lupus Day with announcement of novel biomarker panel to support earlier SLE diagnosis

Pharmacology: Flu vaccine diminished in lupus patients

Patients with the autoimmune disease systemic lupus erythematosus have an increased risk of infection, due to both disturbances in their immune responses and treatment with immunosuppressive drugs.

DNA compounds could treat lupus

A team of researchers has generated DNA-like compounds that effectively inhibit the cells responsible for systemic lupus erythematosus - the most common and serious form of lupus.

Events in lupus

Systemic lupus erythematosus, commonly known as lupus, can affect nearly any part of the body, including the joints, skin, kidneys, heart, nervous system, and brain.





To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited